Clinical Trial Update: Optimizing Dietary Fatty Acids to Lower Metabolic Risk Factors Among Canadians [NA]

View source ↗

Summary

A Canadian clinical trial evaluating optimization of dietary fatty acids to lower metabolic risk factors, including postprandial lipemia, was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postprandial Lipemia

Snippet

Sponsor: University of British Columbia | Conditions: Postprandial Lipaemia | NA | Status: TERMINATED